Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Earnings Per Share Diluted of $5.64 (loss) per share for the year ending 2025.
- Ginkgo Bioworks Holdings, Inc. showed an increase of +46.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Ginkgo Bioworks Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.04 (loss) per share | Q3 2021: $0.08 (loss) per share | Q1 2022: $0.37 (loss) per share | Q2 2022: $0.41 (loss) per share | Q3 2022: $0.41 (loss) per share | Q1 2023: $0.11 (loss) per share | Q2 2023: $0.09 (loss) per share | Q3 2023: $6.21 (loss) per share | Q1 2024: $3.32 (loss) per share | Q2 2024: $4.23 (loss) per share | Q3 2024: $1.08 (loss) per share | Q1 2025: $1.68 (loss) per share | Q2 2025: $1.10 (loss) per share | Q3 2025: $1.45 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), Ginkgo Bioworks Holdings, Inc.'s Earnings Per Share Diluted has declined by 5,540.0%.
- Historical annual values: Fiscal year 2025: $5.64 (loss) per share | Fiscal year 2024: $10.54 (loss) per share | Fiscal year 2023: $18.37 (loss) per share | Fiscal year 2022: $50.20 (loss) per share | Fiscal year 2021: $1.39 (loss) per share | Fiscal year 2020: $0.10 (loss) per share | Fiscal year 2019: $0.10 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: